Potentially
dilutive securities outlined in the table below have been excluded from the computation of diluted net loss per share for the three and
six months ended June 30, 2026 and 2025 because the effect of their inclusion would have been anti-dilutive.
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES
| | |
2026 | | |
2025 | |
| | |
For the three and six months ended June 30, | |
| | |
2026 | | |
2025 | |
| Warrants to purchase shares of Common Stock | |
| 5,876,233 | | |
| 289,701 | |
| Restricted stock units - vested and unissued | |
| 383 | | |
| 258 | |
| Restricted stock units - unvested | |
| 526,186 | | |
| 22,959 | |
| Investment options to purchase shares of Common Stock | |
| 389 | | |
| 389 | |
| Options to purchase shares of Common Stock | |
| 40 | | |
| 128 | |
| Total potentially dilutive securities | |
| 6,403,231 | | |
| 313,435 | |
|